Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings

Shares (Q2 2026)
1,601,182
Value
$3.84M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of LXRX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,601,182$3.84M<0.1%+506,281+46.2%AddedHolders
Q1 20261,094,901$1.71M<0.1%−616,074−36.0%ReducedHolders
Q4 20251,710,975$1.97M<0.1%−923,052−35.0%ReducedHolders
Q3 20252,634,027$3.56M<0.1%+2,634,027NewHolders
Q2 20250$00.0%−406−100.0%Sold outHolders
Q1 2025406$187<0.1%−25,426−98.4%ReducedHolders
Q4 202425,832$19.1K<0.1%−72,792−73.8%ReducedHolders
Q3 202498,624$154.8K<0.1%−2,310,832−95.9%ReducedHolders
Q2 20242,409,456$4.05M<0.1%+2,274,979+1,691.7%AddedHolders
Q1 2024134,477$322.7K<0.1%−651,683−82.9%ReducedHolders
Q4 2023786,160$1.20M<0.1%+784,249+41,038.7%AddedHolders
Q3 20231,911$2.08K<0.1%−410,408−99.5%ReducedHolders
Q2 2023412,319$944.2K<0.1%+301,490+272.0%AddedHolders
Q1 2023110,829$269.3K<0.1%−51,347−31.7%ReducedHolders
Q4 2022162,176$309.8K<0.1%+34,983+27.5%AddedHolders
Q3 2022127,193$306.0K<0.1%−38,486−23.2%ReducedHolders
Q2 2022165,679$308.0K<0.1%−286,133−63.3%ReducedHolders
Q1 2022451,812$945.0K<0.1%+418,766+1,267.2%AddedHolders
Q4 202133,046$130.0K<0.1%−13,810−29.5%ReducedHolders
Q3 202146,856$225.0K<0.1%+35,223+302.8%AddedHolders
Q2 202111,633$54.0K<0.1%−120,859−91.2%ReducedHolders
Q1 2021132,492$778.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.